The wearable technology landscape is on the cusp of a significant transition as ŌURA, the Finnish-founded company...
Evan Lee Salim
Eli Lilly’s highly anticipated triple G agonist, retatrutide, has once again demonstrated remarkable efficacy in late-stage clinical...
GENEVA – Under the banner "Reshaping global health: a shared responsibility," the 79th World Health Assembly (WHA79)...
Jerusalem, Israel – [Date of Publication] – Israel is rapidly solidifying its position as a premier destination...
By Gwendolyn Wu | Published May 20, 2026 In a significant move for the landscape of respiratory...
In a landmark decision that has sent shockwaves through the global pharmaceutical industry, Canada has officially become...
The evolution of modern medicine is increasingly defined by a shift toward the "minimally invasive." As the...
By Tori Ashman | November 12, 2025 For many, the transition from a casual athletic hobby to...
Washington D.C. – In a significant display of industry consensus, hundreds of biopharmaceutical leaders have penned an...
Sun Pharma’s recent announcement of a nearly $12 billion acquisition of Organon represents more than just a...
